Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study)

Autor: M, Echemann, F, Alla, S, Briançon, Y, Juillière, J M, Virion, P M, Mertès, J P, Villemot, F, Zannad, E, Aliot, Ch, Breton, K, KhalifE, J L, Neimann, S, Allam, Ph, Admant, N, Baille, Ph, Bellanger, R, D'Hôtel, P, Dambrine, J F, Dodet, M, Graille, M, Kessler, G, Rebeix, Royer, J P, Saulnier, J Y, Thisse, B, Trutt, Ph, Vidal, M Ch, Vuillemin, Delahaye, P, Ducimetière, F, Fagnani, L, Guize

Publikováno v: European journal of heart failure. 4(5)

Background: In patients with congestive heart failure (CHF), clinical trials have demonstrated the benefit of a number of drugs on morbidity and mortality. Nevertheless so far, there is no published controlled study of long-term antithrombotic therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9e2bb4852e7ff013a59a86826b5273
https://pubmed.ncbi.nlm.nih.gov/12413509

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).

Autor: Echemann M; Service d'Epidémiologie et d'Evaluation cliniques, Hôpital Marin, CHU Nancy, France., Alla F, Briançon S, Juillière Y, Virion JM, Mertès PM, Villemot JP, Zannad F, Aliot E, Breton Ch, KhalifE K, Neimann JL, Allam S, Admant P, Baille N, Bellanger P, D'Hôtel R, Dambrine P, Dodet JF, Graille M, Kessler M, Rebeix G, Royer, Saulnier JP, Thisse JY, Trutt B, Vidal P, Vuillemin MCh, Delahaye, Ducimetière P, Fagnani F, Guize L

Publikováno v: European journal of heart failure [Eur J Heart Fail] 2002 Oct; Vol. 4 (5), pp. 647-54.